Browsing by Author Chewaskulyong B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2001Combination of gemcitabine and cisplatin in advanced non-small cell lung cancerThongprasert S.; Chewaskulyong B.; Pothirat C.
2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerThongprasert S.; Permsuwan U.; Ruengorn C.; Charoentum C.; Chewaskulyong B.
2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerThongprasert S.; Permsuwan U.; Ruengorn C.; Charoentum C.; Chewaskulyong B.
2013Human urinary GM2-activator protein as a potential biomarker for lung cancerPotprommanee L.; Ma H.-T.; Chen C.-H.; Aobchey P.; Boonyapranai K.; Chewaskulyong B.; Sangthong P.; Shank L.; Chen S.-T.
1998Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancerChewaskulyong B.; Thongprasert S.
1-Dec-2012Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the Palliative Performance Scale (PPSv2)Chewaskulyong B.; Sapinun L.; Downing G.; Intaratat P.; Lesperance M.; Leautrakul S.; Somwangprasert A.; Leerapun T.
2008Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patientsCressey R.; Pimpa S.; Chewaskulyong B.; Lertprasertsuke N.; Saeteng S.; Tayapiwatana C.; Kasinrerk W.
2008Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patientsCressey R.; Pimpa S.; Chewaskulyong B.; Lertprasertsuke N.; Saeteng S.; Tayapiwatana C.; Kasinrerk W.
2004Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancerThongprasert S.; Chewaskulyong B.